Sunitinib Treatment for Multiple Brain Metastases from Jejunal Gastrointestinal Stromal Tumor: Case Report
Gastrointestinal stromal tumors (GISTs) are rare malignant tumors and only a few reported cases of brain metastases can be found. Introduction of a new molecular targeted agent, imatinib mesylate in the last decade has dramatically changed the treatment strategy and prognosis. However, imatinib is u...
Main Authors: | , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
The Japan Neurosurgical Society
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533502/ |